首页> 外文期刊>International Orthopaedics >Reinfection after two-stage revision for periprosthetic infection of total knee arthroplasty.
【24h】

Reinfection after two-stage revision for periprosthetic infection of total knee arthroplasty.

机译:两阶段翻修后的再感染,用于全膝关节置换术的假体周围感染。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Limited data exist regarding the long-term results or risk factors for failure after two-stage reimplantation for periprosthetic knee infection. The purpose of this retrospective review was to investigate infection-free implant survival and identify variables associated with reinfection after this procedure. Furthermore, a staging system was evaluated as a possible prognostic tool for patients undergoing two-stage reimplantation of infected total knee arthroplasty (TKA). METHODS: In this level II, retrospective prognostic study, 368 patients with infected TKA treated with a two-stage revision protocol at our institution between 1998 and 2006 were reviewed. Patients who developed recurrent infection and an equal number of patients randomly selected for the control group were analysed for risk factors associated with treatment failure. RESULTS: At the most recent follow-up, 58 (15.8%) patients had developed reinfection after the two-stage reimplantation. The median time to reinfection was 1,303 days (3.6 years), with follow-up time ranging from six to 2,853 days (7.8 years). The strongest positive predictors of treatment failure included chronic lymphoedema [hazard ratio (HR) = 2.28, 95% confidence interval (CI) 1.16-4.48; p = 0.02),and revision between resection and definitive reimplantation (HR = 2.13, 95% CI 1.20-3.79; p = 0.01, whereas patients treated with intravenously administered Cefazolin had a significant reduction in recurrent infection rate (HR = 0.48, 95% CI 0.25-0.90; p = 0.02). CONCLUSIONS: Our findings should be of help in counselling patients regarding their prognosis when faced with two-stage exchange for infected TKA and provide a basis for future comparisons.
机译:目的:关于假肢周围感染两阶段再植入后的长期结果或失败的危险因素的数据有限。这项回顾性研究的目的是调查无感染的植入物存活率,并确定该手术后与再感染相关的变量。此外,分期系统被评估为接受感染的全膝关节置换术(TKA)两阶段再植入的患者的可能预后工具。方法:在该II级回顾性预后研究中,我们对1998年至2006年间采用两阶段修订方案治疗的368例TKA感染患者进行了回顾。分析发生复发感染的患者和随机选择作为对照组的同等数量的患者与治疗失败相关的危险因素。结果:在最近的随访中,两阶段再植入后58例(15.8%)患者发生了再感染。中位再感染时间为1,303天(3.6年),随访时间为6到2,853天(7.8年)。治疗失败的最强阳性预测指标包括慢性淋巴水肿[危险比(HR)= 2.28,95%置信区间(CI)1.16-4.48; p = 0.02),以及在切除和最终再植之间的翻修(HR = 2.13,95%CI 1.20-3.79; p = 0.01,而静脉注射头孢唑林治疗的患者复发感染率显着降低(HR = 0.48,95% CI 0.25-0.90; p = 0.02)结论:我们的研究结果对当患者面对感染性TKA进行两阶段交换时,可为患者的预后提供咨询,并为将来的比较提供依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号